Market Snapshot:
An implanted port (also known as a port) is similar to an artificial vein. It will make accessing your blood vessels for prescriptions and tests easier for your doctors and nurses. An implanted port can be used for a variety of things, including administering intravenous (IV) medicines, IV fluids, nourishment, or both, drawing blood for tests, administering blood transfusions, and administering chemotherapy. Implantable ports are widely used among children, this is mainly because it protects them from potentially harmful drugs and difficultly of accessing vessels in them. In the following years, the pediatric implanted port industry is expected to grow at a rapid rate. The use of pediatric implants in chronic illness, parenteral nutrition, and pain control is becoming more common. Furthermore, the rising prevalence of these disorders is expected to enhance the market for pediatric implanted ports. Children have a lower immune system than adults, making them more susceptible to infection. Pediatric implantable ports' ability to reduce the risk of infection is projected to drive the worldwide pediatric implantable port market.
Highlights from Pediatric Implantable Port Market Study
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
The key Players profiled in the report are AngioDynamics (United States), Smiths Medical (United States), C. R. Bard (United States), Cook Medical (United States), Fresenius Kabi (Germany), Vygon SA (France), Districlass (France) and PakuMed (Germany). Additionally, other players that are part of this comprehensive study are Isomed (India) and Aesculap, Inc (United States).
Geographic Breakdown and Segment Analysis
The Global Pediatric Implantable Port market presents a comprehensive analysis of the Pediatric Implantable Port market by product type (Titanium Port Body and Plastic Port Body), by end-user/application (Cancer, End-Stage Renal Disease and Diabetes), and by geography (North America, South America, Europe, Asia-Pacific and MEA) along with country level break-up. This section of our report presents a realistic picture of the Global Pediatric Implantable Port industry. Investors and Players can easily understand the inherent opportunities and challenges for their products in geographical region of interest.
For instance, while the holds majority of market share of the Pediatric Implantable Port market
Analyst at AMA have segmented the market study of Global Pediatric Implantable Port market by Type, Application and Region.
Market Growth Drivers:
Increasing Prevalence of Infectious Diseases among the Pediatric Population and Development of Health Care Infrastructure for Pediatric Health Issues
Challenges:
Stringent Regulations Related to Drug Approval
Restraints:
High Cost Associated with Implementation of Predictive Analysis
Opportunities:
Increase in Funding for Pediatric Research and Awareness Regarding Pediatric Care
Market Developments Activities:
In March 2024, Billionaire Gautam Adani-run Adani Ports and Special Economic Zone will buy a 95% stake in Odisha's Gopalpur Port (GPL) for an equity value of Rs 1,349 crore and enterprise value of Rs 3,080 crore to boost its east coast presence, the company
Regulatory Insights:
Pediatric Implantable Port Devices require Premarket approval by FDA. Premarket approval (PMA) is the FDA process of scientific and regulatory review to evaluate the safety and effectiveness of Class III medical devices. Also they have to adhere to various rules set by FDA on Pedriatic devices.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Key Target Audience
Pharmaceutical companies, Medical Companies, Hospitals, Medical Research Companies and Regulatory Bodies